FluoroSpot Plus: Human IFN-γ (490) FSP-01A-2 from Mabtech AB

Product Specs
ItemFluoroSpot Plus: Human IFN-γ (490)
CompanyMabtech AB
Price $585.00Supplier Page View Company Product Page
Catalog NumberFSP-01A-2
Quantity2 plate
ApplicationsFluoroSpot
Reactivityhuman
Detection TargetIFN-γ
Formatpre-coated plates
NCBI Full Gene Nameinterferon gamma
NCBI Gene AliasesIFG, IFI, IMD69
ComponentsBAM-conjugated detection mAb (7-B6-1),Anti-BAM-490,Anti-CD3 mAb,Anti-CD28 mAb (CD28-A),FluoroSpot enhancer,Pre-coated FluoroSpot plates (mAb 1-D1K)

Add to Compare List

Mabtech AB

Box 1233

Nacka Strand, SE-131 28

Sweden

Phone: +46 8 716 27 00
+46 8 716 27 01

Company Profile

Website: http://www.mabtech.com

(1) Chikungunya virus-specific CD4+ T cells are associated with chronic chikungunya viral arthritic disease in humansCell Reports MedicineMay 20, 2025Rimjhim Agarwal, James Chang, Fernanda H. Côrtes, Calvin Ha, John Villalpando, Izabella N. Castillo, Rosa Isela Gálvez, Alba Grifoni, Alessandro Sette, Claudia M. Romero-Vivas, et al.Ab,Southern Biotech,Cat# 2014-09; RRID:AB_2795582 FluoroSpot: Human IFNγ (490),"Mabtech, Sweden",Cat# FSP-01A-2 ,, Biological samples,Biological samples,Biological samples ,, CHIKV infected and uninfected blood

(2) Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2NatureAugust 1, 2021Collier DA, Ferreira IATM, Kotagiri P, Datir RP, Lim EY, Touizer E, Meng B, Abdullahi A, CITIID-NIHR BioResource COVID-19 Collaboration., Elmer A, et al.

(3) Impact of SARS-CoV-2 variants on the total CD4⁺ and CD8⁺ T cell reactivity in infected or vaccinated individualsCell reports. MedicineJuly 20, 2021Tarke A, Sidney J, Methot N, Yu ED, Zhang Y, Dan JM, Goodwin B, Rubiro P, Sutherland A, Wang E, et al.

(4) Prognostic significance of interleukin-17A-producing colorectal tumour antigen-specific T cellsBritish journal of cancerApril 1, 2021Thomson A, Bento DFC, Scurr MJ, Smart K, Somerville MS, Keita ÅV, Gallimore A, Godkin A.

(5) Shared recognition of citrullinated tenascin-C peptides by T and B cells in rheumatoid arthritisJCI insightMarch 8, 2021Song J, Schwenzer A, Wong A, Turcinov S, Rims C, Martinez LR, Arribas-Layton D, Gerstner C, Muir VS, Midwood KS, et al.

(6) Characterization of ascites- and tumor-infiltrating γδ T cells reveals distinct repertoires and a beneficial role in ovarian cancerScience translational medicineJanuary 20, 2021Foord E, Arruda LCM, Gaballa A, Klynning C, Uhlin M.

(7) Efficacy, immunogenicity, and safety of an oral influenza vaccine: a placebo-controlled and active-controlled phase 2 human challenge studyThe Lancet. Infectious diseasesApril 1, 2020Liebowitz D, Gottlieb K, Kolhatkar NS, Garg SJ, Asher JM, Nazareno J, Kim K, McIlwain DR, Tucker SN.

(8) Th1 memory differentiates recombinant from live herpes zoster vaccinesThe Journal of clinical investigationOctober 1, 2018Levin MJ, Kroehl ME, Johnson MJ, Hammes A, Reinhold D, Lang N, Weinberg A.

(9) Memory B Cells Activate Brain-Homing, Autoreactive CD4⁺ T Cells in Multiple SclerosisCellSeptember 20, 2018Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, et al.

(10) Strong and frequent T-cell responses to the minor allergen Phl p 12 in Spanish patients IgE-sensitized to ProfilinsAllergyMay 1, 2018Lund G, Brand S, Ramos T, Jimeno L, Boissy P, Vega F, Arina M, Christensen LH, Hoof I, Meno KH, et al.

(11) Personalized adoptive immunotherapy for patients with EBV-associated tumors and complications: Evaluation of novel naturally processed and presented EBV-derived T-cell epitopesOncotargetJanuary 12, 2018Bieling M, Tischer S, Kalinke U, Blasczyk R, Buus S, Maecker-Kolhoff B, Eiz-Vesper B.

(12) Microbiota epitope similarity either dampens or enhances the immunogenicity of disease-associated antigenic epitopesPloS oneJanuary 1, 2018Carrasco Pro S, Lindestam Arlehamn CS, Dhanda SK, Carpenter C, Lindvall M, Faruqi AA, Santee CA, Renz H, Sidney J, Peters B, et al.

(13) Adaptive from Innate: Human IFN-γ⁺CD4⁺ T Cells Can Arise Directly from CXCL8-Producing Recent Thymic Emigrants in Babies and AdultsJournal of immunology (Baltimore, Md. : 1950)September 1, 2017Das A, Rouault-Pierre K, Kamdar S, Gomez-Tourino I, Wood K, Donaldson I, Mein CA, Bonnet D, Hayday AC, Gibbons DL.

(14) Human Cytomegalovirus (HCMV)-Specific CD4⁺ T Cells Are Polyfunctional and Can Respond to HCMV-Infected Dendritic Cells In VitroJournal of virologyMarch 15, 2017Jackson SE, Sedikides GX, Mason GM, Okecha G, Wills MR.

(15) Markers of Protection in Children and Adolescents Six to Fourteen Years After Primary Hepatitis B Vaccination in Real Life: A Pilot StudyThe Pediatric infectious disease journalMarch 1, 2016Brunskole Hummel I, Huber B, Wenzel JJ, Jilg W.

(16) Characteristics of immune memory 10-15 years after primary hepatitis B vaccinationVaccineJanuary 27, 2016Brunskole Hummel I, Zitzmann A, Erl M, Wenzel JJ, Jilg W.

(17) Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccinePloS oneJanuary 1, 2015Weinberg A, Muresan P, Richardson KM, Fenton T, Dominguez T, Bloom A, Watts DH, Abzug MJ, Nachman SA, Levin MJ, et al.

(18) Stepping up ELISpot: Multi-Level Analysis in FluoroSpot AssaysCellsNovember 27, 2014Janetzki S, Rueger M, Dillenbeck T.

Be the First to Write a Review!

FluoroSpot Plus: Human IFN-gamma (490)

FluoroSpot Plus: Human IFN-γ (490) from Mabtech AB

Description

Mabtech AB

Citations (18)

Reviews

FluoroSpot Plus: Human IFN-γ (490) from Mabtech AB

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map